BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rose S, Cuvellier M, Ezan F, Carteret J, Bruyère A, Legagneux V, Nesslany F, Baffet G, Langouët S. DMSO-free highly differentiated HepaRG spheroids for chronic toxicity, liver functions and genotoxicity studies. Arch Toxicol 2021. [PMID: 34762139 DOI: 10.1007/s00204-021-03178-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Donato MT, Gallego-ferrer G, Tolosa L. In Vitro Models for Studying Chronic Drug-Induced Liver Injury. IJMS 2022;23:11428. [DOI: 10.3390/ijms231911428] [Reference Citation Analysis]
2 Liao FC, Wang YK, Cheng MY, Tu TY. A Preliminary Investigation of Embedding In Vitro HepaRG Spheroids into Recombinant Human Collagen Type I for the Promotion of Liver Differentiation. Polymers (Basel) 2022;14:1923. [PMID: 35567092 DOI: 10.3390/polym14091923] [Reference Citation Analysis]
3 Barranger A, Le Hégarat L. Towards better prediction of xenobiotic genotoxicity: CometChip technology coupled with a 3D model of HepaRG human liver cells. Arch Toxicol 2022. [PMID: 35419617 DOI: 10.1007/s00204-022-03292-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kassotis CD, Vom Saal FS, Babin PJ, Lagadic-Gossmann D, Le Mentec H, Blumberg B, Mohajer N, Legrand A, Munic Kos V, Martin-Chouly C, Podechard N, Langouët S, Touma C, Barouki R, Ji Kim M, Audouze K, Choudhury M, Shree N, Bansal A, Howard S, Heindel JJ. Obesity III: Obesogen assays: Limitations, strengths, and new directions. Biochem Pharmacol 2022;:115014. [PMID: 35393121 DOI: 10.1016/j.bcp.2022.115014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]